Funding Rounds Bullish 6

PharmEasy Founders' All Home Raises ₹200Cr, Doubles Valuation to ₹2,000Cr

· 4 min read ·
Share

Key Takeaways

  • The second act from PharmEasy's founding team is off to a fast start.
  • All Home's ₹200 crore funding round and annualised ₹400 crore run rate validate its vision for the building materials sector, while its investor backing highlights continued faith in the team.

Mentioned

All Home company Bessemer Venture Partners company Stride Ventures company Dharmil Sheth person Dhaval Shah person Hardik Dedhia person Siddharth Shah person PharmEasy company Colour Coats company House of W company

Key Intelligence

Key Facts

  1. 1All Home raised Rs 200 crore in a round led by Bessemer Venture Partners, with debt from Stride Ventures, doubling its valuation to Rs 2,000 crore.
  2. 2The startup reported Rs 180 crore in revenue for its first full fiscal year (FY2026) and is tracking an annualised revenue run rate of Rs 400 crore.
  3. 3It previously raised $20 million (~Rs 180 crore) in seed funding in June 2025 at a valuation of around Rs 1,000 crore.
  4. 4All Home operates across four categories (surfaces, hardware and bath fittings, facades and windows, lighting) and partners with seven brands including Colour Coats and House of W.
  5. 5The founding team previously co-founded PharmEasy, one of India's largest digital healthcare platforms.
  6. 6The company plans to use the capital to strengthen its technology stack, set up experience centres, and build state-of-the-art manufacturing facilities.

India's booming real estate sector and the premiumisation of residential, hospitality and commercial spaces are driving demand for better products. Consumers today want greater transparency about what goes into their spaces, how the final outcome will look, and access to the best available options.

Dhaval Shah Co-founder, All Home

Explaining the market opportunity for All Home's funding round

Analysis

After scaling PharmEasy, the founding team ventures into building materials. Within a year, All Home has doubled its valuation to ₹2,000 crore on the back of ₹200 crore in fresh funds, signaling strong investor conviction in second-time founders despite a cautious market.

All Home, the Mumbai-based interiors and building materials startup founded by the quartet behind PharmEasy, has secured Rs 200 crore in a fresh equity-and-debt funding round, doubling its valuation to Rs 2,000 crore within a year of its seed raise. The round was led by existing investor Bessemer Venture Partners, with debt financing from Stride Ventures. The capital infusion marks a significant bet on the fragmented building materials sector by a team that previously built one of India’s largest digital healthcare platforms.

Dharmil Sheth, Dhaval Shah, Hardik Dedhia, and Siddharth Shah built PharmEasy—a company that faced its own share of dramatic highs and lows, including a public-market listing that faltered.

The funding trajectory itself tells a story of rapid scaling. In June 2025, All Home raised $20 million (~Rs 180 crore) at a valuation of approximately Rs 1,000 crore. Now, just 12 months later, the post-money valuation has jumped to Rs 2,000 crore, reflecting both aggressive execution and investor confidence in the founding team. The company reports that it closed fiscal year 2026—its first full year of operations—with Rs 180 crore in revenue, and it is already tracking an annualised revenue run rate of Rs 400 crore. Such growth, in an industry traditionally dominated by unorganised players and local distributors, signals that the market is ready for a tech-enabled intermediary.

The core problem that All Home addresses is well understood in real estate and interior design: the procurement process for high-quality building materials is highly fragmented. Designers and architects must coordinate with multiple vendors, wait through long turnaround times, and struggle with after-sales support. All Home positions itself as a full-stack consumer company, not merely a marketplace. It partners with manufacturing brands—currently seven across surfaces, hardware, bath fittings, facades, windows, and lighting—by investing in them and providing technology, internet-led manufacturing processes, distribution channels, and market insights. This vertical integration allows it to control quality and delivery timelines, a stark departure from the conventional dealer network.

The founders explicitly highlight the technology angle. In their statement, they emphasised “deep manufacturing technology” and a “proprietary technology stack” that will enable both design transparency for customers and efficient production for partners. The plan is to use the fresh capital to strengthen that tech stack, expand a network of physical experience centres, and build state-of-the-art manufacturing facilities. This hints at a broader ambition: to become a dominant player in India’s building materials market by combining online discovery with offline touchpoints, much like a digitally native vertical brand.

From a market perspective, the timing appears favourable. India’s real estate sector is booming, and the trend toward premiumisation—across residential, hospitality, and commercial spaces—is driving demand for superior, design-forward products. Consumers increasingly want to know the source and composition of materials, as well as visualise the final outcome before purchasing. All Home’s model promises exactly that: a curated, transparent, and cohesive experience. Moreover, the building materials market in India is estimated at over $50 billion, yet organised retail penetration remains low, leaving a vast addressable market for a player that can aggregate demand and standardise quality.

What to Watch

For investors, the story carries the weight of a seasoned founding team. Dharmil Sheth, Dhaval Shah, Hardik Dedhia, and Siddharth Shah built PharmEasy—a company that faced its own share of dramatic highs and lows, including a public-market listing that faltered. That experience, however, likely shaped their operational discipline and fundraising acumen. Bessemer Venture Partners, a firm known for backing Indian consumer-tech winners, has doubled down on the team. The presence of debt financing from Stride Ventures also indicates an asset-heavy strategy, as the company plans to invest in physical infrastructure.

Looking ahead, All Home will face execution challenges typical of manufacturing-tech ventures: scaling production while maintaining quality, managing inventory, and competing with entrenched local suppliers. Yet the rapid revenue ramp and the doubling of valuation suggest strong early product-market fit. If All Home can replicate its online-to-offline success, it may not only transform building materials procurement but also serve as a blueprint for tech-driven consolidation in other fragmented industrial sectors. The next 12–18 months will test whether this second act can surpass the highs—and avoid the lows—of the founders’ first venture.

Timeline

Timeline

  1. Seed Funding Round

  2. Series A Funding Round

How we covered this story

Every story in our startup coverage is assembled from multiple primary sources, cross-referenced for factual consistency, and scored along three independent dimensions: sentiment, operational impact, and source-cluster confidence. Single-source rumors and unverifiable claims do not pass our editorial gate. When a story shows "Verified by N sources" with N≥2, the development is independently corroborated; when N=1, we mark it explicitly so readers can weigh the signal accordingly.

Impact scoring uses a 1-10 scale weighted toward regulatory, financial, and operational consequence rather than coverage volume. A topic that runs in every outlet but moves no real decisions ranks lower than a niche regulatory filing that reshapes how operators in the startup space have to behave. Read our full methodology for the scoring rubric, our glossary for term definitions, and our trends index for the longitudinal view across the beat.